Opportunities for Value Creation

There are multiple opportunities for different stakeholders like drug development heads, regulators, pharmacists, technocrats, doctors, manufacturers and more. These can be delivered separately or in combination and will require the different entities in the ecosystem to interact in non-traditional ways

Product Developnment

Service Delivery

Insight Generation

Information Brokerage

Holistic Solution Provision

Performance Management

Key Discussion Points

ET DRUG DELIVERY AND FORMULATION SUMMIT

Response, Recover and Thrive have been around for a while. Not only as individuals we are strengthening ourselves for a new normal comeback, but the trend is across nations and industries. Pharmaceuticals is among one of those sectors in the throes of big change. With the start of COVID 19 to the day today, the world has been rolling through the stages of response, recovery, thriving and mitigating.

Global pharmaceutical markets are in the midst of major discontinuities. While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. The treatment of serious illnesses is no longer exclusively being used traditional drugs, as they are starting to be replaced using biologic, or biopharmaceutical, treatments.

Attendees

API manufacturers

Drug Delivery devices manufacturers

Controlled released technologies companies

Prefilled syringes technology companies

Contract Manufacturing companies

Bulk Drug Manufacturers

Excipients suppliers

Plant Directors. Plant Heads, QA

QC Head, CQH, Drug development heads

Principal scientist

R&D Heads

Tech Transfer Scientist

Manufacturing Heads

WANT TO KNOW MORE ABOUT THE SUMMIT?